Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric Cancer
Clinical trial NCT00450203 · UNKNOWN
Trial details
- NCT number
- NCT00450203
- Sponsor
- Professor David Cunningham
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2017-12-01
- Enrollment
- 1103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.